Valuation: Simulations Plus, Inc.

Market Cap 37Cr 32Cr 30Cr 27Cr 52Cr 3.55TCr 52Cr 352.93Cr 137.99Cr 1.78TCr 139.34Cr 136.31Cr 5.91TCr P/E 2026 *
43.7x
P/E 2027 * 40.1x
Enterprise Value 37Cr 32Cr 30Cr 27Cr 52Cr 3.55TCr 52Cr 352.93Cr 137.99Cr 1.78TCr 139.34Cr 136.31Cr 5.91TCr EV / Sales 2026 *
4.53x
EV / Sales 2027 * 4.3x
Free-Float
83.09%
Yield 2026 *
-
Yield 2027 * -
1 day+0.25%
1 week+0.19%
Current month+0.69%
1 month+0.69%
3 months+37.59%
6 months+49.35%
Current year+0.69%
1 week 18.3
Extreme 18.3
18.37
1 month 18.19
Extreme 18.19
18.39
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
51.22
5 years 11.09
Extreme 11.09
67.59
10 years 7.9
Extreme 7.9
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
03/08/26 Sell

Executive/Senior Manager

-1,000 0.0050%
06/07/26 Sell

Executive/Senior Manager

-1,000 0.0050%
01/07/26 Sell

Founder

-4,177 0.0207%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+0.19%+28.90%-60.96% 37Cr
-3.52%+5.76%-13.14%+26.98% 3.96TCr
-1.27%-0.48%-44.68%+147.97% 1.32TCr
+1.72%+5.91%-18.62%+66.69% 573.77Cr
+35.70%+46.01%+35.00% - 365.9Cr
+4.06%+8.99% - - 200.74Cr
-0.90%+1.33%+17.70%-41.20% 170.14Cr
-3.16%-5.28%-40.41% - 97Cr
+1.97%+0.86%+38.78%+130.05% 92Cr
-0.82%+0.28%-32.47%-45.83% 84Cr
Average +3.36%+3.61%-3.21%+31.95% 690.45Cr
Weighted average by Cap. -0.25%+5.36%-16.11%+54.48%

Financials

2026 *2027 *
Net sales 8.19Cr 7.07Cr 6.64Cr 6.04Cr 11Cr 782.88Cr 12Cr 78Cr 30Cr 392.04Cr 31Cr 30Cr 1.3TCr 8.63Cr 7.45Cr 7Cr 6.37Cr 12Cr 824.82Cr 12Cr 82Cr 32Cr 413.04Cr 32Cr 32Cr 1.37TCr
Net income 95.34L 82.34L 77.38L 70.37L 1.32Cr 91Cr 1.34Cr 9.07Cr 3.54Cr 46Cr 3.58Cr 3.5Cr 151.71Cr 1.02Cr 87.94L 82.63L 75.15L 1.41Cr 97Cr 1.44Cr 9.68Cr 3.79Cr 49Cr 3.82Cr 3.74Cr 162.01Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
14/26/14 $18.35 +0.22% 2,14,624
13/26/13 $18.31 -0.05% 1,51,224
12/26/12 $18.32 +0.05% 1,82,253
11/26/11 $18.31 -0.22% 2,47,707
10/26/10 $18.35 +0.16% 1,95,010
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.35USD
Average target price
17.25USD
Spread / Average Target
-5.99%

Quarterly revenue - Rate of surprise